Real-World Prescribing Patterns and Clinical Characteristics of Patients With Type 2 Diabetes Mellitus Receiving Empagliflozin-Sitagliptin-Metformin Fixed-Dose Combination Therapy. (PubMed, Cureus) - Sep 24, 2026 - "Empagliflozin-based triple FDC therapy was prescribed among Indian patients with T2DM, particularly older adults with cardiometabolic comorbidities. Distinct prescribing patterns and clinical characteristics observed between ESM-25 and ESM-10 therapy may reflect individualized treatment selection in routine clinical practice."
Journal • Real-world evidence • Cardiovascular • Diabetes • Hypertension • Metabolic Disorders • Type 2 Diabetes Mellitus
|
|
Aadil B Wasil; Ankit Chhabra; Ashish Patel; Balaji T Naik; Debasish Patro; Dilip Gude; George Paulose; Gurunath Chavan; Manoj Gaur; N Thyagarajan; Pradip Mate; Rohan Kate; Shrimant Y; Sumit Sarkar; Suryakant Pankaj; Utsa Basu
|